BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15553042)

  • 1. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
    Boeckh M; Kim HW; Flowers ME; Meyers JD; Bowden RA
    Blood; 2006 Mar; 107(5):1800-5. PubMed ID: 16282339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuation.
    Feng CJ; Zhao P; Fu HX; Yan CH; Wang CC; Zhu XL; He Y; Wang FR; Zhang YY; Mo XD; Kong Y; Han W; Wang JZ; Wang Y; Chen H; Chen YH; Zhao XY; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Am J Hematol; 2024 Apr; 99(4):633-641. PubMed ID: 37772366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.
    Barnabas RV; Baeten JM; Lingappa JR; Thomas KK; Hughes JP; Mugo NR; Delany-Moretlwe S; Gray G; Rees H; Mujugira A; Ronald A; Stevens W; Kapiga S; Wald A; Celum C;
    J Infect Dis; 2016 Feb; 213(4):551-5. PubMed ID: 26142452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with Brivudine in Immunocompromised Pediatric Patients with Herpes Zoster.
    Vogel C; Wetzel L; Wutzler P; Gruhn B
    Chemotherapy; 2023; 68(4):222-227. PubMed ID: 37231819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.
    Jamani K; MacDonald J; Lavoie M; Williamson TS; Brown CB; Chaudhry A; Jimenez-Zepeda VH; Duggan P; Tay J; Stewart D; Daly A; Storek J
    Blood Adv; 2016 Dec; 1(2):152-159. PubMed ID: 29296807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable Clinical Courses of Varicella Zoster Virus Infection-related or Vaccination-related Bone Marrow Failure.
    Toskov V; Cseh A; Claviez A; Drexler B; Rotari N; Schwarz-Furlan S; Braun M; Bader P; Lang P; Beier R; Erdlenbruch B; Führer M; Erlacher M; Niemeyer CM; Strahm B; Yoshimi A
    J Pediatr Hematol Oncol; 2024 Apr; ():. PubMed ID: 38652069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abdominal pain as the initial symptom of visceral varicella zoster infection in hematopoietic stem cell transplant recipients].
    Muñoz L; Balmaña J; Martino R; Sureda A; Rabella N; Brunet S
    Med Clin (Barc); 1998 Jun; 111(1):19-22. PubMed ID: 9666431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.